10X GENOMICS INC-CLASS A (TXG)
US88025U1097 - Common Stock
10X GENOMICS INC-CLASS A
NASDAQ:TXG (5/14/2024, 7:06:06 PM)
After market: 26.56 0 (0%)26.56
-0.41 (-1.52%)
Company Profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. The company is headquartered in Pleasanton, California and currently employs 1,243 full-time employees. The company went IPO on 2019-09-12. The firm's integrated platform solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, Visium Spatial Proteogenomics and Xenium In Situ Gene Expression. Its patent portfolio comprises over 1,750 issued patents and patent applications.
Company Info
10X GENOMICS INC-CLASS A
6230 Stoneridge Mall Road
Pleasanton CALIFORNIA 94588
P: 19254017300
CEO: Serge Saxonov
Employees: 1243
Website: https://www.10xgenomics.com/
TXG News
5 days ago - InvestorPlaceShhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s RadarYou might want to get in on these three under-the-radar nanotech stocks before Wall Street catches on to the technology's potential.
8 days ago - InvestorPlaceCathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough OfCathie Wood stock picks focus on the big ideas she has on where the future will be. Sometimes it means her picks will be down more for longer.
8 days ago - Market News VideoFirst Week of TXG July 19th Options Trading
12 days ago - 10x Genomics, Inc.10x Genomics to Present at the BofA Securities 2024 Healthcare Conference/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will...
13 days ago - InvestorPlace3 Gene Editing Stocks with the Potential to Make You an Overnight MillionairePay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.
14 days ago - ChartmillThese stocks are moving in today's pre-market sessionGet insights into the top gainers and losers of Wednesday's pre-market session.
TXG Twits
Here you can normally see the latest stock twits on TXG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
